GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Circio Holding ASA (OSL:CRNA) » Definitions » Cyclically Adjusted PB Ratio

Circio Holding ASA (OSL:CRNA) Cyclically Adjusted PB Ratio : 0.02 (As of Jun. 13, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Circio Holding ASA Cyclically Adjusted PB Ratio?

As of today (2024-06-13), Circio Holding ASA's current share price is kr2.70. Circio Holding ASA's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was kr179.18. Circio Holding ASA's Cyclically Adjusted PB Ratio for today is 0.02.

The historical rank and industry rank for Circio Holding ASA's Cyclically Adjusted PB Ratio or its related term are showing as below:

OSL:CRNA' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.01   Med: 0.04   Max: 0.1
Current: 0.01

During the past years, Circio Holding ASA's highest Cyclically Adjusted PB Ratio was 0.10. The lowest was 0.01. And the median was 0.04.

OSL:CRNA's Cyclically Adjusted PB Ratio is ranked better than
99.85% of 661 companies
in the Biotechnology industry
Industry Median: 1.7 vs OSL:CRNA: 0.01

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Circio Holding ASA's adjusted book value per share data for the three months ended in Dec. 2023 was kr-12.890. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is kr179.18 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Circio Holding ASA Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Circio Holding ASA's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Circio Holding ASA Cyclically Adjusted PB Ratio Chart

Circio Holding ASA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 0.04

Circio Holding ASA Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Jun23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 0.09 0.04

Competitive Comparison of Circio Holding ASA's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Circio Holding ASA's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Circio Holding ASA's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Circio Holding ASA's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Circio Holding ASA's Cyclically Adjusted PB Ratio falls into.



Circio Holding ASA Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Circio Holding ASA's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=2.70/179.18
=0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Circio Holding ASA's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Circio Holding ASA's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-12.89/131.9000*131.9000
=-12.890

Current CPI (Dec. 2023) = 131.9000.

Circio Holding ASA Quarterly Data

Book Value per Share CPI Adj_Book
201309 0.000 96.400 0.000
201312 0.606 96.600 0.827
201403 0.000 97.300 0.000
201406 160.596 97.500 217.258
201409 151.691 98.500 203.127
201412 151.499 98.600 202.664
201503 136.143 99.200 181.021
201506 37.364 100.100 49.234
201509 383.502 100.600 502.822
201512 370.350 100.900 484.134
201603 340.881 102.500 438.656
201606 0.000 103.800 0.000
201609 240.846 104.200 304.871
201612 223.873 104.400 282.843
201703 211.138 105.000 265.230
201706 203.430 105.800 253.615
201709 238.370 105.900 296.893
201712 230.473 106.100 286.516
201803 214.014 107.300 263.080
201806 197.222 108.500 239.757
201809 181.723 109.500 218.897
201812 170.256 109.800 204.524
201903 153.971 110.400 183.956
201906 136.636 110.600 162.950
201909 128.391 111.100 152.428
201912 114.947 111.300 136.222
202003 132.162 111.200 156.764
202006 116.675 112.100 137.283
202009 111.175 112.900 129.885
202012 105.644 112.900 123.423
202103 96.347 114.600 110.892
202106 90.896 115.300 103.983
202109 84.511 117.500 94.868
202112 66.543 118.900 73.819
202203 60.851 119.800 66.997
202206 59.110 122.600 63.594
202209 57.037 125.600 59.898
202212 0.408 125.900 0.427
202306 -10.643 130.400 -10.765
202312 -12.890 131.900 -12.890

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Circio Holding ASA  (OSL:CRNA) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Circio Holding ASA Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Circio Holding ASA's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Circio Holding ASA (OSL:CRNA) Business Description

Traded in Other Exchanges
Address
Vollsveien 19, Lysaker, Oslo, NOR, 1366
Circio Holding ASA is a clinical-stage company. It is focused on developing and commercializing immuno-oncology therapies to target treatment-resistant solid tumors. Its product candidate, ONCOS-102, is a genetically modified oncolytic adenovirus, which has been engineered to infect cancer cells and activate the immune system to fight cancer. It includes the development and implementation with the purpose of developing targeted immunotherapy treatments for cancer patients.

Circio Holding ASA (OSL:CRNA) Headlines

No Headlines